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Abstract Identi¢cation of physiological substrates for Cdc2/
cyclin B is crucial for understanding the functional link between
mitotic events and Cdc2/cyclin B activation. A human homologue
of the Drosophila warts tumor suppressor, termed WARTS, is a
serine/threonine kinase and a dynamic component of the mitotic
apparatus. We have found that Cdc2/cyclin B forms a complex
with a fraction of WARTS in the centrosome and phosphory-
lates the Ser613 site of WARTS during mitosis. Immunocyto-
chemical analysis has shown that the S613-phosphorylated
WARTS appears in the spindle poles at prometaphase and dis-
appears at telophase. Our ¢ndings suggest that Cdc/cyclin B
regulates functions of WARTS on the mitotic apparatus.
* 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The activation of the Cdc2/cyclin B complex is known to
play a crucial role in the onset of mitosis and the regulation of
subsequent mitotic events such as centrosome separation,
chromosome condensation, nuclear envelope breakdown,
and microtubular reorganization by phosphorylating target
proteins [1]. For instance, the Cdc2/cyclin B complex was
shown to phosphorylate nuclear lamin thus leading to its dis-
assembly, an important event in the initiation of nuclear en-
velope breakdown [2]. In addition, the complex associated
with aster and mitotic spindles is involved in the rearrange-
ment of the microtubule network during mitosis, by phos-
phorylating proteins that localize spindle pole bodies. How-
ever, there is little clear evidence to account for a functional
link between mitotic events and phosphorylation of Cdc2 sub-
strates. Therefore, identi¢cation of physiological substrates of
the Cdc2/cyclin B complex and the spatial and temporal reg-
ulation of the enzyme^substrate interaction remain important
goals to understanding the molecular mechanisms by which
the Cdc2/cyclin B complex initiates mitosis and brings about
subsequent cell cycle events [3].
The warts gene (also referred to as lats) was identi¢ed from
its ability to act as a tumor suppressor in Drosophila mela-
nogaster [4]. The warts/lats protein has a serine/threonine ki-
nase domain, which is highly homologous to those of the
human myotonic dystrophy protein kinase (DMPK) family
proteins, and DMPK family kinases have been shown to be
generally involved in various mitotic events. A human homo-
logue of warts/lats, termed WARTS (also referred to as
LATS1), has been identi¢ed recently [5,6], and mice de¢cient
in the warts/lats homologue have been shown to develop ma-
lignant tumors analogous to its mutant in Drosophila [7]. Im-
munolocalization studies have found the human WARTS ki-
nase at the centrosome in interphase cells, while it becomes
localized to the mitotic apparatus, including spindle poles and
mitotic spindles, in metaphase^anaphase, and ¢nally, to the
midbody by telophase [6]. Moreover, WARTS protein was
found to be mitotically phosphorylated and to interact with
zyxin, a regulator of actin ¢lament assembly, on the mitotic
apparatus during mitosis, and this mitosis-speci¢c interaction
has been demonstrated to play a critical role in controlling
mitosis progression [8]. All these ¢ndings suggest that
WARTS is involved in various mitotic events in mammalian
cells and that inactivation of its function may result in failure
of normal mitotic progression, leading to chromosomal insta-
bility.
In this study, we demonstrate that WARTS is a physiolog-
ical substrate of Cdc2/cyclin B and show characteristic local-
ization of the phosphorylated form of WARTS during mito-
sis.
2. Materials and methods
2.1. Synchronization
HeLa cells were synchronized at the beginning of S phase by the
double thymidine block and release protocol as previously described
[8]. S phase cells were collected 2 h after release from the second
thymidine release. Mitotic cells were collected by mechanical shake-
o¡ from the culture plate 9.5 h after release from S phase.
2.2. In vitro kinase assay
HeLa cells (5U105) were collected and washed in ice-cold phos-
phate-bu¡ered saline. Cell extract was prepared and subjected to ki-
nase reaction [8]. Kinase reaction was conducted at 25‡C for 30 min in
a ¢nal volume of 50 Wl containing 20 mM Tris, pH 7.4, 10 mM
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MgCl2, 10 WCi of [Q-32P]ATP (3000 Ci/mmol; Amersham Pharmacia),
1 Wg microcystin, 8 Wg of cell extract or 2.5 Wl of puri¢ed active Cdc2
[9], and 10 Wg of glutathione S-transferase (GST) fusion protein. As
control reactions, we used the catalytic subunit of protein kinase A
(PKA) (bovine heart) (Calbiochem), the catalytic subunit of protein
kinase C (PKC) (rat brain) (Calbiochem), and puri¢ed calmodulin
kinase II (CaMKII) (provided by Dr. H. Yamamoto, Kumamoto
University, Japan). Each reaction mixture was mixed with 30 Wl of
glutathione-agarose beads (50% slurry). After the incubation, the
beads were washed and boiled in 30 Wl of Laemmli sample bu¡er to
elute GST fusion proteins. The sample were resolved by 12% SDS^
PAGE and visualized by autoradiography.
2.3. Depletion of Cdc2
Aliquots of 150 Wl of mitotic cell extracts (1 mg/ml) were incubated
with 50 Wl of p13-suc1 agarose beads (50% slurry; Upstate Biotech-
nology) at 4‡C for 45 min. After centrifugation, 50 Wl of fresh p13-
suc1 beads was added to the supernatant and incubated for an addi-
tional 30 min.
2.4. Gel ¢ltration chromatography
Ten dishes (10 cm diameter) of con£uent nocodazole-treated HeLa
cells were lysed in 1 ml of lysis bu¡er, subjected to three cycles of
rapid freezing in liquid nitrogen and thawing at 4‡C, and then cen-
trifuged at 100 000Ug for 30 min at 4‡C. The supernatants were
applied to a Superdex 200 column which was equilibrated with equil-
ibrated bu¡er (20 mM Tris^HCl pH 8.0, 150 mM NaCl, 1 mM di-
thiothreitol). The elution was performed with the same bu¡er at a
£ow rate of 250 Wl/min. An aliquot of each fraction was subjected
to in vitro kinase assay and immunoblot analysis.
2.5. Peptide synthesis and production of antibodies
Phosphorylated Ser613 peptide PS613 (CKQITTpS613PITVR: pS
represents phosphoserine) and Ser613 (CKQITTSPITVR) were chemi-
cally synthesized by Peptide Institute (Osaka, Japan). Antibody
against PS613 was prepared by injecting rabbits with PS613 coupled
to keyhole limpet hemocyanin. Speci¢c antibody against PS613,
termed PS613 Ab, was puri¢ed from the obtained serum by two-
step chromatography as previously described [10]: a⁄nity chromatog-
raphy on PS613-coupled Cellulo¢ne (Seikagaku Corp.) and then ab-
sorption in S613-coupled Cellulo¢ne.
2.6. Immuno£uorescence microscopy
HeLa cells were grown on a 35 mm Petri dish to 70% con£uence
and pretreated with a microtubule-stabilizing bu¡er [11]. After being
washed, cells were incubated with the following antibodies: rat anti-
WARTS antibody (G3) [8], rabbit anti-pSer613 antibody (PS613 Ab),
and monoclonal mouse anti-Q-tubulin (GTU-88). This was followed
by incubation with FITC- or Texas red-conjugated secondary anti-
body. The stained cells were mounted and observed with confocal
microscopy (Fluoview; Olympus).
2.7. Immunoprecipitation and immunoblots
Cells were lysed on ice for 30 min with 1% Nonidet P-40 lysis bu¡er
[8]. Lysates were centrifuged (14 000Ug, 20 min, 4‡C). Aliquots of
supernatant (0.2^2.0 mg/ml) were incubated for 2 h at 4‡C with spe-
ci¢c antibodies, and another 2 h incubation after adding 30 Wl of
protein A Sepharose1 4 Fast Flow (50% slurry; Amersham Pharma-
cia Biotech). Immunoprecipitates were washed three times with lysis
bu¡er before Laemmli sample bu¡er was added. The samples were
resolved by SDS^PAGE and transferred to nitrocellulose for immu-
noblotting.
3. Results
3.1. Mitosis-speci¢c phosphorylation of human WARTS by
Cdc2/cyclin B
We have reported previously that WARTS is phosphorylat-
ed during mitosis [6]. To delineate the mitosis-speci¢c phos-
phorylation region of WARTS, we generated three GST-
WARTS truncated mutants, GST-WP, -WN and -WK
(Fig. 1A) and utilized them as substrates for in vitro kinase
assays. Interphase and nocodazole-treated mitotic phase ly-
sates of HeLa cells were used as kinase fractions. Among
these GST fusion proteins, GST-WN (amino acids 395^700)
was phosphorylated speci¢cally by nocodazole-treated cell ly-
sate (Fig. 1B, lane 4).
We next examined whether the phosphorylation of GST-
WN in mitotic extracts is dependent on Cdc2 kinase. GST-
Fig. 1. Determination of a region in WARTS protein speci¢cally phosphorylated by mitotic lysate. A: Schematic diagram of GST-WARTS de-
letion mutants showing their domain structures. The deletion mutants containing amino acids 136^403, 395^700 and 682^1130 of WARTS were
designated GST-WP, GST-WN and GST-WK, respectively. B: In vitro phosphorylation of WARTS protein. GST-WP, GST-WN and GST-
WK were incubated with either interphase (I) or nocodazole-treated (Noc) cell lysate in the presence of [Q-32P]ATP. Samples were analyzed by
SDS^PAGE followed by autoradiography.
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WN phosphorylation diminished signi¢cantly when Cdc2 was
depleted from mitotic extracts of HeLa cells using p13suc1
beads (Fig. 2A, lane 2). But the mock-depleted mitotic ex-
tracts could phosphorylate GST-WN (Fig. 2A, lane 3). Fur-
thermore, we found that the puri¢ed Cdc2/cyclin B complex
directly phosphorylated GST-WN (Fig. 2B). These ¢ndings
indicate that GST-WN is speci¢cally phosphorylated by
Cdc2/cyclin B, which is contained in mitotic cell lysate.
To examine whether endogenous WARTS associates with
the Cdc2/cyclin B during mitosis, we separated proteins ex-
tracted from HeLa cells blocked in mitosis with nocodazole
by HPLC using a Superdex 200 column (Fig. 2C). Individual
fractions were assayed for GST-WN phosphorylation activity
and were subjected to Western blot analysis. We found that
the phosphorylated WARTS detected as a slower mobility
band was cofractionated with Cdc2 and cyclin B in the frac-
tions exhibiting GST-WN phosphorylation activity (fractions
57^59). Because Q-tubulin, a component of the centrosome,
Fig. 2. Phosphorylation of WARTS by Cdc2/cyclin B complex. A: E¡ect of Cdc2 depletion on the in vitro phosphorylation of WARTS by mi-
totic lysate. GST-WN was incubated with either bu¡er alone (lane 1), Cdc2-depleted mitotic lysate (lane 2), or mock-depleted mitotic cell lysate
(lane 3) in the presence of [Q-32P]ATP. B: In vitro phosphorylation of WARTS by Cdc2. GST-WN was incubated with (+) or without the puri-
¢ed active Cdc2/cyclin B complex (3) in the presence of [Q-32P]ATP. C: Nocodazole-treated lysates from HeLa cells were separated on a Super-
dex 200 column. The eluted proteins in each fraction were subjected to in vitro kinase assays (top panel) and immunoblotting with indicated
antibodies. Arrow and arrowhead indicate hyperphosphorylated and hypophosphorylated WARTS proteins, respectively.
Fig. 3. Determination of Cdc2 phosphorylation sites in the WN region of WARTS. A series of GST-WN mutants were analyzed by in vitro ki-
nase assay to determine the phosphorylation sites in the WN region. In each GST-WN mutant, one of the putative Cdc2 phosphorylation sites
(Ser444, Thr490, Ser530, Ser613, or Ser635) was changed to alanine. GST-WN and the mutant proteins were incubated with mitotic lysates of
HeLa cells (A) or puri¢ed active Cdc2/cyclin B1 complex (B) in the presence of [Q-32P]ATP.
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was also detected in those fractions, the WARTS^Cdc2^cyclin
B complex appears to be localized to the centrosome during
mitosis. Although fraction 55 also contained both WARTS
and cyclin B, the WARTS protein detected in fraction 55
appeared to be a non-phosphorylated fast migrating form
and was cofractionated with cyclin B but not with Cdc2. In
addition, fractions 67^69, where a large amount of free Cdc2
exists, did not contain the WARTS protein. Thus, these ¢nd-
ings suggest that a fraction of WARTS is associated with the
Cdc2/cyclin B complex in the centrosomes and is phosphory-
lated by the complex during mitosis.
3.2. Identi¢cation of the mitosis-speci¢c phosphorylation sites
in WARTS
To determine the phosphorylation sites in the WN region of
the WARTS protein, a series of GST-WN mutants were gen-
erated and subjected to an in vivo kinase assay. It was pre-
viously shown that Ser/Thr-Pro is the minimum consensus
motif for Cdc2 kinase phosphorylation [10,12^14]. Therefore,
we generated GST-WN mutants in which one of the putative
Cdc2 phosphorylation sites (Ser444, Thr490, Ser530, Ser613,
or Ser635) was replaced with alanine. While S444A, S530A
and S635A mutants, as well as wild-type WN, were highly
phosphorylated by mitotic lysate, the phosphorylation of
T490A and S613A mutants was markedly diminished (Fig.
3A). Additionally, the T490A and S613A mutants showed
signi¢cant reductions of phosphorylation by the puri¢ed ac-
tive Cdc2/cyclin B complex (Fig. 3B). These results suggest
that Thr490 and Ser613 in WARTS are potential phosphory-
lation sites for Cdc2 during mitosis.
3.3. Production of the site- and phosphorylation state-speci¢c
antibody for WARTS
Next, we investigated how the mitosis-speci¢c phosphory-
lation of WARTS is regulated in space and time in living cells.
While Thr490 is not conserved among di¡erent species, Ser613
is evolutionarily conserved in all warts/lats homologues (Dro-
sophila, chicken, mouse, rat, and human) [6], suggesting that
phosphorylation of the Ser613 site is biologically important.
Therefore, we attempted to generate a rabbit polyclonal anti-
body (referred to as PS613 Ab) that speci¢cally recognizes the
phosphorylated state of WARTS at Ser613. Immunoblot
analyses revealed that PS613 Ab speci¢cally reacted with the
GST-WN phosphorylated by lysates extracted from nocoda-
zole-treated cells (Fig. 4A, lane 3) and cells at mitosis (Fig.
4B) but did not detect the GST-WN treated with interphase
cell lysates. The S613A mutant of GST-WN treated with no-
codazole-treated lysates was not recognized by PS613 Ab
(Fig. 4A, lane 4). Furthermore, PS613 Ab reacts with the
GST-WN phosphorylated by puri¢ed Cdc2/cyclin B but not
with those treated with PKA, PKC and CaMKII (Fig. 4C).
Taken together, PS613 Ab speci¢cally recognizes the phos-
phorylation of WARTS at Ser613 by Cdc2 kinase.
3.4. Ser613 of endogenous WARTS is phosphorylated during
mitosis
We next examined whether the Ser613 site of WARTS is
phosphorylated in living cells. The endogenous WARTS was
immunoprecipitated from the interphase, mitotic and nocoda-
zole-treated mitotic lysates with anti-WARTS polyclonal anti-
body (C-2), which recognizes both phosphorylated and non-
phosphorylated forms of WARTS, and subsequently blotted
with either C-2 antibody or PS613 Ab. As shown in Fig. 5A,
the S613-phosphorylated WARTS, designated pSer613-
WARTS, was more abundantly detected in the mitotic lysate
and nocodazole-treated HeLa cells lysates than in the inter-
phase lysates. This result suggests that the Ser613 site of en-
dogenous WARTS is phosphorylated during mitosis.
3.5. Subcellular localization of Ser613-phosphorylated WARTS
Subcellular localization of pSer613-WARTS was investi-
gated by immunocytochemical analysis using the PS613 anti-
body (Fig. 5B). When cells were stained with G3 antibody
that recognizes both non-phosphorylated and phosphorylated
WARTS, WARTS was predominantly detected at centro-
somes in interphase cells and became localized to the mitotic
spindles and spindle poles in a highly dynamic manner during
mitosis (Fig. 5B, a^f) as we described previously [6,8]. Con-
trary to the G3 staining, pSer613-WARTS was not observed
Fig. 4. Development of antibodies that recognize a mitotic speci¢c
phosphorylation site (Ser613) in WARTS. A: Speci¢city of phos-
phorylation site-speci¢c antibodies (PS613 Ab). GST-WN and GST-
WN(S613A) mutant, which were incubated with lysates prepared
from interphase cells (I) and nocodazole-treated cells (Noc), were re-
solved by SDS^PAGE followed by immunoblotting with PS613 Ab.
The lower band in lane 3 was found to be a proteolytic product of
GST-WN generated during protein preparation. B: PS613 Ab reacts
with Ser613 phosphorylated by mitotic lysate. HeLa cells were
synchronized at the beginning of S phase. Following release from
S phase, cells were harvested at the indicated time points. GST-WN,
which was incubated with lysates prepared from the harvested cells,
was subjected to immunoblot with PS613 Ab. C: PS613 Ab recog-
nizes Ser613 phosphorylated by Cdc2. GST-WN, which was incuba-
ted with the puri¢ed active Cdc2/cyclin B complex, PKA, PKC, or
CaMKII, was subjected to immunoblot with PS613 Ab.
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at centrosomes in interphase cells (Fig. 5B, g^i). In the cells
that underwent nuclear envelope breakdown, pSer613-
WARTS staining was detected at the centrosomes. At meta-
phase, both spindle poles were brightly labeled by PS613 and
the mitotic spindles were stained weakly (Fig. 5B, j^l). The
staining at the spindle poles decreased from anaphase to te-
lophase. These ¢ndings support our biochemical data that a
fraction of WARTS is phosphorylated at the Ser613 site by
Cdc2 kinase at the spindle pole bodies during mitosis.
4. Discussion
In the present paper we demonstrated that the middle re-
gion of WARTS, designated the WN region, is phosphorylat-
ed during mitosis. Three lines of evidence suggest that the
mitosis-speci¢c phosphorylation of the WN region is mediated
by activated Cdc2. First, the depletion of Cdc2 from mitotic
cell lysates markedly abolished phosphorylation of GST-WN
in vitro. Second, puri¢ed active Cdc2/cyclin B complex phos-
phorylated GST-WN. Third, the phosphorylated form of en-
dogenous WARTS was eluted with the active Cdc2/cyclin B
complex in the same fractions of size exclusion gel chroma-
tography.
In vitro kinase assays using a series of GST-WN mutants
revealed that Thr490 and Ser613 are sites phosphorylated by
both mitotic lysate and puri¢ed active Cdc2/cyclin B. Since
amino acid sequences around Ser613 site are completely con-
served in warts/lats homologues identi¢ed in di¡erent species,
we generated antibodies speci¢cally recognizing the phosphor-
ylated state of WARTS at Ser613. PS613 Ab speci¢cally re-
acted with the endogenous WARTS when the cells are at
mitosis or treated with nocodazole, indicating that the
Ser613 site of WARTS is mitotically phosphorylated in vivo.
In the late G2 phase, maturation promoting factor (MPF),
composed of cyclin B and Cdc2, appears in the centrosomes
and subsequently translocates into the nucleus at prophase.
Fig. 5. Ser613-phosphorylated WARTS is localized to spindle poles during mitosis. A: Phosphorylation of endogenous WARTS during mitosis.
Lysates prepared from interphase (I), mitotic (M) and nocodazole-treated (Noc) HeLa cells were immunoprecipitated with anti-WARTS anti-
body (C-2). The immunoprecipitates were resolved by SDS^PAGE followed by immunoblotting with anti-WARTS antibody (C-2) (left panel)
or PS613 Ab (right panel). B: Subcellular localization of pSer613-WARTS. HeLa cells at interphase (a^c and g^i) and mitotic phase (d^f and
j^l) were ¢xed and labeled with G3 antibodies which recognize both non-phosphorylated and phosphorylated WARTS (a and d) or labeled
with PS613 (g and j). WARTS was visualized by FITC-conjugated secondary antibody (green). K-Tubulin (e and k) and Q-tubulin (b and h)
were visualized by Texas red-conjugated secondary antibody (red). The merged images are shown in c, f, i and l. Arrowheads indicate centro-
somes found in interphase cells, which were visualized by Q-tubulin antibody.
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About 20 min after the nuclear translocation of MPF, nuclear
envelope breakdown occurs, and then, MPF binds to the mi-
totic apparatus, in particular to centrosomes and mitotic spin-
dles [15]. In addition, MPF associated with centrosomes and
mitotic spindles is considered to be involved in the rearrange-
ment of the microtubule network at mitosis by phosphorylat-
ing certain centrosomal proteins. We previously reported that
a fraction of WARTS protein is localized at the centrosome in
interphase and translocated dynamically toward mitotic spin-
dles in metaphase^anaphase, and, ¢nally, located at the mid-
body by telophase [6,8]. Immuno£uorescence studies using
PS613 Ab revealed that phosphorylation of Ser613 by
WARTS occurred at centrosomes in prometaphase. This
phosphorylation continued at centrosomes and mitotic spin-
dles in anaphase, and disappeared in telophase. Localization
and the timing of phosphorylation of the Ser613 site are con-
sistent with the localization and timing of activation of the
Cdc2/cyclin B complex during mitosis.
We previously showed that zyxin interacts with WARTS on
the mitotic apparatus [8]. We found that the WARTS binding
domain of zyxin is masked by the NH2-terminal region in
interphase cells and that the phosphorylation of the NH2-ter-
minal region of zyxin by Cdc2/cyclin B allows zyxin to inter-
act with WARTS during mitosis. Those ¢ndings together with
data in this study suggest that Cdc2/cyclin B is required for
formation of the WARTS^zyxin complex on the mitotic ap-
paratus to execute normal mitosis.
We have recently found that WARTS kinase activity is still
low in cells arrested at prometaphase by treatment with no-
codazole when Cdc2/cyclin B is highly activated. However,
WARTS is signi¢cantly activated at 10 min after release
from nocodazole treatment, when cells are at anaphase (Iida
et al., manuscript in preparation). These ¢ndings suggest that
phosphorylation of WARTS by Cdc2/cyclin B is not su⁄cient
for activation of WARTS kinase and that an additional
event(s) is required for its activation at the metaphase^ana-
phase transition. It can be speculated that phosphorylation of
WARTS by Cdc2/cyclin B promotes a protein complex for-
mation on the mitotic apparatus at early mitosis, which may
be required for subsequent activation of WARTS kinase at
the metaphase^anaphase transition.
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